Lippis Daniel J. bought EW
May 18, 2026 · Form 4 insider transaction
Lippis Daniel J. bought 620 shares of Edwards Lifesciences Corporation at $72.68 per share, a transaction worth $45.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
620
Price
$72.68
Total value
$45.1K
InsiderLippis Daniel J.
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 18, 2026
Filing dateMay 18, 2026
Shares owned after41,031
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.